Novavax Expands Operations with up to 850 New Hires in Maryland
Gaithersburg's Novavax, a clinical stage vaccine company developing promising vaccines for RSV, Influenza, and Ebola announces plans to expand its operations in Montgomery County adding up to 850 new jobs to its current 400+ workforce.
BioHealth and Life Sciences News
Gaithersburg's Emergent BioSolutions receives a BARDA contract valued at up to $21.9M to develop and manufacture three cGMP lots of a Zika vaccine for use in a Phase 1 clinical trial. The company also receives FDA Orphan Drug status for its BioThrax vaccine.
Rockville's GlycoMimetics' GMI-1271 receives FDA Fast Track Designation for treatment of AML. The company also announces pricing of public offering of common stock.
Gaithersburg's Opgen closes a $10.4M private placement to advance its molecular diagnostics and bioinformatics technology focused on multi-drug resistant organisms.
Baltimore's Lupin Limited receives FDA approvals for generic Activella® and Vfend® Tablets and Vfend® Oral Suspension.
Germantown's Neuralstem plans to raise $1.08M and announces positive data regarding its NSI-189 technology.
Gaithersburg's GenVec, a clinical-stage gene delivery company, announces a $5M at-the-market offering to advance its cutting-edge therapeutics and vaccines.
Baltimore's Cerecor announces a $1M R&D grant from the National Inst. on Drug Abuse.
Baltimore's Noxilizer announces FDA 510(k) clearance of a medical device sterilized using the company's nitrogen dioxide sterilization process.
Germantown's Senseonics, developing a long-term, implantable continuous glucose monitoring system, signs exclusive distribution agreement with Roche.
Rockville's MacroGenics presents data from Phase 1 study of MGD010 at EULAR 2016.
Baltimore's WellDoc® announces positive results regarding use of its digital health product and also expands its leadership team with roster of seasoned healthcare executives.
Gaithersburg's Vtesse advances Phase 2b/3 clinical trial of VTS-270 in Niemann-Pick Type C1 Disease.
Rockville's CASI Pharmaceuticals receives approval from CFDA to conduct Phase 2 clinical trials with ENMD-2076 for Fibrolamellar Carcinoma (FLC).
Germantown's Epigenomics' Epi proColon test--the first and only FDA approved blood test for colon cancer, is included now in the USPSTF guidelines for colorectal cancer screening.
Baltimore's Clear Guide Medical recieves a patent for its innovation image fusion product.
Rockville's ABL and REGENXBIO to manufacture HoFH treatment for human clinical trials.
Columbia's Osiris' Grafix demonstrates superior clinical outcomes compared with EpiFix.
Baltimore's eNeura, Inc. receives CE Mark label extension expanding use of SpringTMS to include migraine prevention.
Rockville's REGENXBIO and Biogen enter exclusive license agreement for the development of gene therapy treatments for rare genetic vision disorders.
Poolesville High School senior Anantha Sriya Reddy wins MD BioGENEius contest. .
Baltimore's Sonavex named ICOY Life Sciences Company of the year.
The Maryland Department of Commerce focuses on attracting, retaining, and expanding businesses and creating jobs in Maryland, and also markets Maryland's many assets to companies across the nation and abroad. The Department's Office of BioHealth and Life Sciences supports innovative start-ups and companies focused on animal and human health, health IT, research tools, and related technologies.
